R. Brent Wisner

Brent Wisner Named One of America’s Most Influential Trial Lawyers

Jan. 22, 2019 – Miami, Florida - - The National Law Journal and the Trial Lawyer Magazine named Baum, Hedlund, Aristei & Goldman attorney and partner, R. Brent Wisner, one of America’s 50 Most Influential Trial Lawyers for his success over the past year. The outstanding civil plaintiff and criminal [...]

Baum Hedlund Earns 2019 Trial Team of the Year Award for Monsanto Case

Jan. 21, 2019 – Miami, Florida - - The National Trial Lawyers Top 100 recognized the law firms of Baum, Hedlund, Aristei & Goldman, the Miller Firm and Audet & Partners with the 2019 Trial Team of the Year award (in the Mass Torts category) for their work in the [...]

Baum Hedlund Aristei & Goldman Recognized as 2018 Elite Trial Lawyers

Dec. 5, 2018 – Los Angeles, California - - The National Law Journal has recognized the law firm of Baum, Hedlund, Aristei & Goldman in its 2018 Elite Trial Lawyers list for pharmaceutical litigation based on the firm’s work in a high-profile case against drug manufacturer GlaxoSmithKline. Baum, Hedlund, Aristei [...]

Bayer CEO Open to Roundup Settlements Following Verdict and Stock Hit

Nov. 6, 2018 – St. Louis, Missouri - - Bayer AG’s chief executive officer Werner Baumann said the company could consider Monsanto settlements to resolve Roundup cancer lawsuits filed in courts throughout the United States, depending on court costs. Baumann made the comments last week to German media invited to tour Bayer’s new [...]

By | 2019-06-28T14:49:45+00:00 November 6th, 2018|Monsanto Roundup News, R. Brent Wisner|

Attorneys Discuss Monsanto Roundup Litigation at UCLA Law Event

Nov. 5, 2018 – Los Angeles, California - - Baum, Hedlund, Aristei & Goldman attorneys Michael L. Baum, R. Brent Wisner and Pedram Esfandiary participated in a panel discussion on October 31 at an event held by the University of California, Los Angeles School of Law. The lunchtime panel before [...]

Judge Denies Monsanto’s Bid for New Trial in Roundup Cancer Case

Oct. 22, 2018 – San Francisco, California - - A California state court judge ruled today to uphold a jury’s verdict against Monsanto stemming from the Roundup lawsuit to proceed to trial. In August, a San Francisco jury returned a verdict in favor of Dewayne “Lee” Johnson, a former groundskeeper who [...]

By | 2019-07-08T15:22:40+00:00 October 22nd, 2018|Monsanto Roundup News, R. Brent Wisner|

R. Brent Wisner to Speak About Monsanto Trial at Harvard Law School

Sept. 28, 2018 – Cambridge, Massachusetts - - Baum, Hedlund, Aristei & Goldman attorney and partner R. Brent Wisner will be appearing at Harvard Law School today to discuss the landmark $289.2 million against Monsanto in the first Roundup cancer case to proceed to trial. Wisner will speak in front [...]

By | 2018-10-01T18:52:33+00:00 September 28th, 2018|Blog, Monsanto Roundup News, Press Releases, R. Brent Wisner|

Brent Wisner Recognized in Daily Journal Top 100 Lawyers for 2018

Sept. 19, 2018 – Los Angeles, California - - Baum, Hedlund, Aristei & Goldman attorney and partner R. Brent Wisner was named to the Daily Journal’s list of the “Top 100 Lawyers in California” for 2018. As the publication notes, Wisner led the charge in handing agrochemical giant Monsanto Company [...]

By | 2019-01-18T15:57:45+00:00 September 19th, 2018|Press Releases, R. Brent Wisner|

Baum, Hedlund, Aristei & Goldman Attorneys Speak at Yale Law School

Sept. 17, 2018 – New Haven, Connecticut -- Baum, Hedlund, Aristei & Goldman attorneys Michael L. Baum and R. Brent Wisner will participate today in a conference organized by Yale Law School’s Collaboration for Research Integrity and Transparency (CRIT) program. The conference, Challenging Court Secrecy in Medical Product Litigation, is scheduled to take place at Yale [...]

By | 2019-01-18T15:58:42+00:00 September 17th, 2018|Blog, Monsanto Roundup News, Michael L. Baum, R. Brent Wisner|

Widow of Reed Smith Attorney Seeks Paxil Suicide Rehearing

Sept. 10, 2018 – CHICAGO, IL - - The Seventh Circuit Court of Appeals panel that overturned a $3 million verdict against GlaxoSmithKline (GSK) for failing to include a suicide warning on the company’s antidepressant, Paxil, committed a “grave error,” said plaintiff Wendy Dolin in a petition for rehearing. Dolin’s attorneys, R. Brent Wisner, Michael L. [...]

By | 2019-04-17T14:41:58+00:00 September 10th, 2018|Blog, Press Releases, Michael L. Baum, Bijan Esfandiari, R. Brent Wisner|